Baldetorp B - Search Results

1

Landscape of somatic allelic imbalances and copy number alterations in HER2-amplified breast cancer.

Staaf J, Jönsson G, Ringnér M, Baldetorp B, Borg A. Staaf J, et al. Among authors: baldetorp b. Breast Cancer Res. 2011;13(6):R129. doi: 10.1186/bcr3075. Epub 2011 Dec 14. Breast Cancer Res. 2011. PMID: 22169037 Free PMC article.

2

Landscape of somatic allelic imbalances and copy number alterations in human lung carcinoma.

Staaf J, Isaksson S, Karlsson A, Jönsson M, Johansson L, Jönsson P, Botling J, Micke P, Baldetorp B, Planck M. Staaf J, et al. Among authors: baldetorp b. Int J Cancer. 2013 May 1;132(9):2020-31. doi: 10.1002/ijc.27879. Epub 2012 Oct 20. Int J Cancer. 2013. PMID: 23023297

3

Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization.

Rennstam K, Ahlstedt-Soini M, Baldetorp B, Bendahl PO, Borg A, Karhu R, Tanner M, Tirkkonen M, Isola J. Rennstam K, et al. Among authors: baldetorp b. Cancer Res. 2003 Dec 15;63(24):8861-8. Cancer Res. 2003. PMID: 14695203

4

Predicting continuous values of prognostic markers in breast cancer from microarray gene expression profiles.

Gruvberger-Saal SK, Edén P, Ringnér M, Baldetorp B, Chebil G, Borg A, Fernö M, Peterson C, Meltzer PS. Gruvberger-Saal SK, et al. Among authors: baldetorp b. Mol Cancer Ther. 2004 Feb;3(2):161-8. Mol Cancer Ther. 2004. PMID: 14985456

5

Cytogenetic characterization and gene expression profiling of the trastuzumab-resistant breast cancer cell line JIMT-1.

Rennstam K, Jönsson G, Tanner M, Bendahl PO, Staaf J, Kapanen AI, Karhu R, Baldetorp B, Borg A, Isola J. Rennstam K, et al. Among authors: baldetorp b. Cancer Genet Cytogenet. 2007 Jan 15;172(2):95-106. doi: 10.1016/j.cancergencyto.2006.09.014. Cancer Genet Cytogenet. 2007. PMID: 17213017

6

Multiregion Whole-Exome Sequencing Uncovers the Genetic Evolution and Mutational Heterogeneity of Early-Stage Metastatic Melanoma.

Harbst K, Lauss M, Cirenajwis H, Isaksson K, Rosengren F, Törngren T, Kvist A, Johansson MC, Vallon-Christersson J, Baldetorp B, Borg Å, Olsson H, Ingvar C, Carneiro A, Jönsson G. Harbst K, et al. Among authors: baldetorp b. Cancer Res. 2016 Aug 15;76(16):4765-74. doi: 10.1158/0008-5472.CAN-15-3476. Epub 2016 May 23. Cancer Res. 2016. PMID: 27216186

7

c-myc amplification is an independent prognostic factor in postmenopausal breast cancer.

Borg A, Baldetorp B, Fernö M, Olsson H, Sigurdsson H. Borg A, et al. Among authors: baldetorp b. Int J Cancer. 1992 Jul 9;51(5):687-91. doi: 10.1002/ijc.2910510504. Int J Cancer. 1992. PMID: 1612775

8

ERBB2 amplification in breast cancer with a high rate of proliferation.

Borg A, Baldetorp B, Fernö M, Killander D, Olsson H, Sigurdsson H. Borg A, et al. Among authors: baldetorp b. Oncogene. 1991 Jan;6(1):137-43. Oncogene. 1991. PMID: 1671531

9

ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer.

Borg A, Baldetorp B, Fernö M, Killander D, Olsson H, Rydén S, Sigurdsson H. Borg A, et al. Among authors: baldetorp b. Cancer Lett. 1994 Jun 30;81(2):137-44. doi: 10.1016/0304-3835(94)90194-5. Cancer Lett. 1994. PMID: 7912163 Clinical Trial.

10

Prognostic significance of flow cytometric DNA analysis and estrogen receptor content in breast carcinomas--a 10 year survival study.

Ewers SB, Attewell R, Baldetorp B, Borg A, Fernö M, Långström E, Killander D. Ewers SB, et al. Among authors: baldetorp b. Breast Cancer Res Treat. 1992;24(2):115-26. doi: 10.1007/BF01961244. Breast Cancer Res Treat. 1992. PMID: 8443399

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

148 results

Search Page

Filters